Abstract
The aim of the present study was to evaluate the diagnostic yield of prenatal cytogenetic microarray (CMA) in structurally normal and abnormal foetuses and record the acceptance rate of CMA for prenatal diagnosis over a course of five years. In 128 structurally normal and abnormal foetuses, CMA was performed along with foetal karyotype, after exclusion of aneuploidy by quantitative fluorescence polymerase chain reaction. The microarray was able to detect the pathogenic variants in 5.5% cases; the diagnostic yield in structurally abnormal foetuses was 8.8% and 4.7% in foetuses with a high aneuploidy risk. Balanced and unbalanced translocations, and low level mosaicism were detected. Reanalysis of variants of uncertain significance identified pathogenic variant. The study shows higher diagnostic yield in structurally abnormal cases, the importance of foetal karyotype and reanalysis in microarray. The acceptance rate of prenatal CMA increased five-fold over a period of five years.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American College of Obstetricians and Gynecologists Committee on Genetics 2013 Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis. Obstet. Gynecol. 122, 1374–1377.
Boggula V. R., Agarwal M., Kumar R., Awasthi S. and Phadke S. R. 2015 Recurrent benign copy number variants and issues in interpretation of variants of unknown significance identified by cytogenetic microarray in Indian patients with intellectual disability. Indian J. Med. Res. 142, 699–712.
Breman A., Pursley A. N., Hixson P., Bi W. Ward P., Bacino C. A. et al. 2012 Prenatal chromosomal microarray analysis in a diagnostic laboratory; experience with \(>\)1000 cases and review of the literature. Prenat. Diagn. 32, 351–361.
Curran S., Ahn J. W., Grayton H., Collier D. A. and Ogilvie C. M. 2013 NRXN1 deletions identified by array comparative genome hybridisation in a clinical case series—further understanding of the relevance of NRXN1 to neurodevelopmental disorders. J. Mol. Psychiatry 1, 4.
Esplin E. D., Li B., Slavotinek A., Novelli A., Battaglia, Clark R. et al. 2014 Nine patients with Xp22.31 microduplication, cognitive deficits, seizures, and talipes anomalies. Am. J. Med. Genet. A. 164, 2097–2103.
Guella I., McKenzie M. B., Evans D. M., Buerki S. E., Toyota E. B., van Allen M. I. et al. 2017 De Novo mutations in YWHAG cause early-onset epilepsy. Am. J. Hum. Genet. 101, 300–310.
Hillman S. C., McMullan D. J., Hall G., Togneri F. S., James N., Maher E. J. et al. 2013 Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis. Ultrasound Obstet. Gynecol. 41, 610–620.
Liao C., Fu F., Li R., Yang W. Q., Lia H. Y., Yan J. R. et al. 2013 Loss-of-function variation in the DPP6 gene is associated with autosomal dominant microcephaly and mental retardation. Eur. J. Med. Genet. 56, 484–489.
Redon R., Rigler D. and Carter N. P. 2009 Comparative genomic hybridization: DNA preparation for microarray fabrication. Methods Mol. Biol. 529, 259–266.
Shaffer L. G., Dabell M. P., Fisher A. J., Coppinger J., Bandhdz A. M., Ellison J. W. et al. 2012 Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies. Prenat. Diagn. 32, 976–985.
Shinawi M., Liu P., Kang S. H., Shen J., Belmont J. W., Scott D. A. et al. 2010 Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J. Med. Genet. 47, 332–341.
South S. T., Lee C., Lamb A. N., Higgins A. W., Kearney H. M. et al. 2013 Working Group for the American College of Medical Genetics and Genomics Laboratory Quality Assurance Committee. ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013. Genet. Med. 15, 901–909.
Wapner R. J., Martin C. L., Levy B., Ballif B. C., Christine M., Zachary I. M. et al. 2012 Chromosomal microarray versus karyotyping for prenatal diagnosis. N. Engl. J. Med. 367, 2175–2178.
Weiss L. A., Shen Y., Korn J. M., Arking D. E., Miller D. T., Fossdal R. et al. 2008 Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 358, 667–675.
Acknowledgements
We thank ‘Indian Council of Medical Research’ for funding support (ICMR grant number: 63/8/2010-BMS) and we are thankful to the patients’ families for their unending support and patience.
Author information
Authors and Affiliations
Corresponding author
Additional information
Corresponding editor: H. A. Ranganath
Rights and permissions
About this article
Cite this article
Lallar, M., Srivastava, P., Rai, A. et al. Cytogenetic microarray in structurally normal and abnormal foetuses: a five years experience elucidating increasing acceptance and clinical utility. J Genet 98, 6 (2019). https://doi.org/10.1007/s12041-018-1050-5
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12041-018-1050-5